Phase 1 Study Evaluating the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib and Cetuximab in Recurrent/Metastatic p16-Negative Squamous Cell Carcinoma of the Head and Neck

Overview of attention for article published in Frontiers in oncology, March 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 28 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 16 publications that cite this research output.

16

The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.

Combination Therapy as a Promising Way to Fight Oral Cancer

Article in Pharmaceutics (June 2023)

CDK4/6 and autophagy inhibitors synergize to suppress the growth of human head and neck squamous cell carcinomas

Article in Molecular Carcinogenesis (May 2023)

DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival

Article in International Journal of Molecular Sciences (February 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.